Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-11-043621)

Filing Details

Accession Number:: 0001181431-11-043621
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-08-03 14:30:25
Reporting Period:: 2011-08-01

Filing Date:: 2011-08-03
Accepted Time:: 2011-08-03 14:30:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1338042	Aegerion Pharmaceuticals Inc.	AEGR	Pharmaceutical Preparations (2834)	202960116

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1314575	D Marc Beer	C/O Aegerion Pharmaceuticals, Inc. 101 Main Street, Ste 1850 Cambridge MA 02142	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-01	4,938	$15.74	121,690	No	4	P	Direct
Common Stock	Acquisiton	2011-08-01	1,392	$15.74	123,082	No	4	P	Indirect	Roth IRA

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	Roth IRA

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	116,752	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2011.